From a chemical pharmacy standpoint, Relafen 750 ( Naproxen Acid) presents a fascinating case study in drug action. Its mechanism of action primarily involves the inhibition of cyclooxygenase ( COX mediators) enzymes, particularly the COX-2 isoform, leading to a reduction in the synthesis of prostaglandins . This selective inhibition accounts for i